Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says that “Super Intelligence” may be used in place of “Artificial Intelligence” across NIH content, with a link to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:56:35.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T02:43:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site's footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T05:13:18.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message, indicating that access to the study record is blocked. The previous study content appears to be unavailable due to restricted access.
    Difference
    21%
    Check dated 2026-09-20T01:31:58.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s content or formatting.
    Difference
    0.1%
    Check dated 2026-08-30T00:43:24.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.4 to v3.6.5. This indicates a minor, internal update to the page version rather than a substantive change to study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T23:52:05.000Z thumbnail image

Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.